Drug Resistance, Microbial
"Drug Resistance, Microbial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Concept/Terms
Drug Resistance, Microbial- Drug Resistance, Microbial
- Drug Resistances, Microbial
- Antimicrobial Drug Resistance
- Antimicrobial Drug Resistances
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Microbial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Microbial".
This graph shows the total number of publications written about "Drug Resistance, Microbial" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Microbial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 3 | 17 | 20 |
| 1992 | 1 | 30 | 31 |
| 1993 | 3 | 25 | 28 |
| 1994 | 4 | 12 | 16 |
| 1995 | 4 | 15 | 19 |
| 1996 | 7 | 35 | 42 |
| 1997 | 14 | 20 | 34 |
| 1998 | 6 | 37 | 43 |
| 1999 | 7 | 35 | 42 |
| 2000 | 8 | 34 | 42 |
| 2001 | 8 | 26 | 34 |
| 2002 | 4 | 8 | 12 |
| 2003 | 3 | 5 | 8 |
| 2004 | 0 | 4 | 4 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 6 | 8 |
| 2008 | 6 | 1 | 7 |
| 2009 | 2 | 4 | 6 |
| 2010 | 4 | 2 | 6 |
| 2011 | 8 | 6 | 14 |
| 2012 | 1 | 0 | 1 |
| 2013 | 9 | 5 | 14 |
| 2014 | 9 | 9 | 18 |
| 2015 | 9 | 4 | 13 |
| 2016 | 6 | 6 | 12 |
| 2017 | 4 | 9 | 13 |
| 2018 | 10 | 5 | 15 |
| 2019 | 6 | 6 | 12 |
| 2020 | 4 | 5 | 9 |
| 2021 | 1 | 0 | 1 |
Below are the most recent publications written about "Drug Resistance, Microbial" by people in Profiles.
-
Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community. J Bone Joint Surg Am. 2021 01 06; 103(1):4-9.
-
Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. Value Health. 2021 01; 24(1):105-111.
-
The role of "spillover" in antibiotic resistance. Proc Natl Acad Sci U S A. 2020 11 17; 117(46):29063-29068.
-
A Structure-Function-Inhibition Analysis of the Pseudomonas aeruginosa Type III Secretion Needle Protein PscF. J Bacteriol. 2020 08 25; 202(18).
-
Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae. Nat Commun. 2020 08 17; 11(1):4126.
-
Emerging Microbiology Diagnostics for Transplant Infections: On the Cusp of a Paradigm Shift. Transplantation. 2020 07; 104(7):1358-1384.
-
Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. JAMA Netw Open. 2020 04 01; 3(4):e202899.
-
Deciphering the Impact of Bystander Selection for Antibiotic Resistance in Neisseria gonorrhoeae. J Infect Dis. 2020 03 16; 221(7):1033-1035.
-
Discussing the ABCs of Health Security-Antibiotic Resistance, Biothreats, and Coronavirus. JAMA. 2020 Mar 10; 323(10):912-914.
-
Mobilizable antibiotic resistance genes are present in dust microbial communities. PLoS Pathog. 2020 01; 16(1):e1008211.